Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
---|
06/04/1992 | DE4038385A1 Sitosterol and its glycoside(s) with improved bio-availability - are in the form of microemulsions using lecithin as the carrier, isopropyl-myristate as the emulsifier and isopropanol as co-emulsifier |
06/04/1992 | DE4038203A1 Pharmaceutical spray-prepn. for admin. of nitrate(s) - esp. for treatment of cardiovascular, disorders, asthma, migraine and colic |
06/03/1992 | EP0488583A2 Improved kit and method for administration of bacillus calmette-guerin |
06/03/1992 | EP0488401A1 A controlled-release pharmaceutical preparation for intra-ocular implant |
06/03/1992 | EP0488181A1 Hard capsule preparation containing nifedipine |
06/03/1992 | EP0488142A1 Process for encapsulating solid or liquid lipophilic agents in phospholipid-liposomes and medicaments containing those liposomes |
06/03/1992 | EP0488139A1 Pharmaceutical composition comprising calcium polycarbophil |
06/03/1992 | EP0488137A2 Preparation for transdermal drug administration |
06/03/1992 | EP0488089A1 Diclofenac preparations for topical use |
06/03/1992 | EP0487973A1 Topical lotion containing Niclosamide |
06/03/1992 | EP0487774A1 A direct tabletting auxiliary |
06/03/1992 | EP0487768A1 Pharmaceutical composition with improved dissolution property |
06/03/1992 | EP0487729A1 Ketotifen preparation for external use |
06/03/1992 | EP0487632A1 Stabilized vaccine compositions |
06/03/1992 | EP0487615A1 Ferritin analogs. |
06/03/1992 | EP0487603A1 Composition based on hydrated lipidic lamelar phases or on liposomes containing at least one derivative of labdane, or a plant extract containing it; cosmetic or pharmaceutical, particularly dermatological composition containing it. |
06/03/1992 | EP0487575A1 Pharmaceutical formulations. |
06/03/1992 | EP0467954A4 Preparation of liposome and lipid complex compositions |
06/03/1992 | EP0359746B1 Use of vinyl alcohol homopolymers and copolymers for tableting active materials |
06/03/1992 | EP0219539B1 Transdermal nitroglycerin delivery system |
06/03/1992 | CN1061530A Medical health care cloth cushion for protecting chilblain |
06/03/1992 | CN1061527A Quickly effective atomized agent and sprayer for curing a cold and the preparation method thereof |
06/02/1992 | US5118808 Pharmaceutical preparations |
06/02/1992 | US5118779 Hydrophilic polyurethane elastomers |
06/02/1992 | US5118698 Pharmaceutical preparations |
06/02/1992 | US5118671 Complexes of aescin, β-sitosterol or cholesterol, and phospholipids and pharmaceutical compositions containing them |
06/02/1992 | US5118528 Precipitation of film-forming material and biologically active substance from solvent-non-solvent mixture |
06/02/1992 | US5118511 Emulsifier, protective colloid, drug dispersed in very small particles of edible oil or fat |
06/02/1992 | US5118510 Niacin drink mix formulation |
06/02/1992 | US5118509 Inducing skin tolerance to a sensitizing drug |
06/02/1992 | US5118508 Pharmaceutical composition |
06/02/1992 | US5118494 Use of soluble fluorosurfactants for the preparation of metered-dose aerosol formulations |
06/02/1992 | CA1302279C Solid dispersion composition of fr-900506 substance |
06/02/1992 | CA1302278C Injection solutions of torasemide which are ready to use and processes for their preparation thereof |
06/02/1992 | CA1302272C Pharmaceutical compositions containing dipyridamole or mopidamol and o-acetylsalicylic acid or the physiologically acceptable salts thereof, processes for preparing them and theiruse in treating clot formation |
06/02/1992 | CA1302269C Penetrating topical pharmaceutical compositions |
06/02/1992 | CA1302267C Oral therapeutic system having systemic action |
06/02/1992 | CA1302261C Buccal drug dosage form |
06/02/1992 | CA1302260C Drug delivery system and method of making the same |
06/02/1992 | CA1302259C Pharmaceutical formulations |
06/02/1992 | CA1302258C Pharmaceutical compositions comprising microcapsules |
06/02/1992 | CA1302257C Pharmaceutical formulation and a process for its preparation |
06/02/1992 | CA1302256C Topical drug release system |
06/02/1992 | CA1302255C Sustained release dosage form |
06/02/1992 | CA1302148C Method for preparing an effervescent granulate, an effervescent granulate made accordingly, and its utilization |
05/31/1992 | WO1992009263A1 Gel type compositions having improved oil control |
05/31/1992 | CA2056513A1 A controlled-release pharmaceutical preparation for intra-ocular implant |
05/30/1992 | CA2056032A1 Hard capsule preparation |
05/30/1992 | CA2031095A1 Process for producing liquid-loaded powders |
05/29/1992 | WO1992009252A1 Method and device for treating tobacco addiction |
05/29/1992 | WO1992008685A1 Amphiphilic non-ionic, glycerol-derived compounds, a method for preparing same, corresponding intermediate compounds and compositions containing said compounds |
05/29/1992 | WO1992008479A1 Tissue factor based prothrombin time reagent |
05/29/1992 | WO1992008477A1 Therapeutic agent for corneal lesion |
05/29/1992 | WO1992008467A1 Dispersion preparation |
05/29/1992 | WO1992008463A1 Direct compression method for preparing pills having cephalosporanic acid derivatives |
05/29/1992 | WO1992008459A1 Topical compositions for transdermal delivery of produg derivatives of morphine |
05/29/1992 | WO1992008447A1 Aerosol containing medicaments |
05/29/1992 | WO1992008446A1 Aerosol medicaments |
05/29/1992 | WO1992005866A3 Efficient microcapsule preparation and method of use |
05/29/1992 | CA2055715A1 Kit and method for administration of bacillus calmette-guerin |
05/28/1992 | WO1992009299A1 Oral pharmaceutical composition containing cyclosporin and process for preparing same |
05/28/1992 | WO1992009286A1 Composition containing antihistamine h2 receptor antagonists and bioadhesive material |
05/28/1992 | CA2096962A1 Composition containing antihistamine h2 receptor antagonists and bioadhesive material |
05/28/1992 | CA2072983A1 Oral pharmaceutical composition containing cyclosporin and process for preparing same |
05/27/1992 | WO1992009635A1 Methyl pyrrolidinone chitosan, production process and uses thereof |
05/27/1992 | WO1992009283A1 Stabilized hexahydro-5-pyrimidinamine compounds in aqueous solution and methods for preparing same |
05/27/1992 | WO1992009269A1 Oral spiramycine formulations and method for preparing same |
05/27/1992 | EP0487431A1 Laxative compositions and process for their preparation |
05/27/1992 | EP0487335A1 Pharmaceutical dosage forms of dihydropyridines |
05/27/1992 | EP0487066A1 Disinfectant composition |
05/27/1992 | EP0486998A1 Slow-releasing composition of platinum-containing anticancer agent |
05/27/1992 | EP0486964A2 S(+)-Phenyl-alkanoic acids and alpha-hydroxy-alkanoic acids containing complexes |
05/27/1992 | EP0486959A1 Pharmaceutical composition of microparticles with controlled release and process of preparing it |
05/27/1992 | EP0486863A1 Antiacid compositions with prolonged gastric residence time |
05/27/1992 | EP0486854A1 Aqueous compositions containing calcitonin for the nasal administration |
05/27/1992 | EP0486563A1 Chewing gum composition with accelerated, controlled release of active agents. |
05/27/1992 | EP0486529A1 Transdermal nitroglycerin patch with penetration enhancers |
05/27/1992 | EP0486499A1 Stable ascorbic acid compositions. |
05/27/1992 | EP0201601B1 Glass microspheres |
05/27/1992 | DE4036332A1 Opthalmological contact gel - can be used in virectomy to hold contact lenses in place, in three mirror contact glass investigations and in echography |
05/27/1992 | CN2105281U Dental silver amalgam capsule |
05/27/1992 | CN1061405A Complexes containing s(+)-phenyl alkane acids and alpha-hydroxyalkane acids |
05/27/1992 | CN1061404A Complexes containing s(+) phenyl alkane acids and alpha-amino acids |
05/27/1992 | CA2096943A1 Oral spiramycine formulations and method for preparing same |
05/27/1992 | CA2074517A1 Methyl pyrrolidinone chitosan, production process and uses thereof |
05/27/1992 | CA2074484A1 Stabilized hexahydro-5-pyrimidinamine compounds in aqueous solution and methods for preparing same |
05/26/1992 | US5117022 Antitumor |
05/26/1992 | US5116878 Medicinal composition for the treatment and prevention of the symptoms of heart failure, containing a vasoconstrictor alpha-stimulant agent as active principle |
05/26/1992 | US5116868 Glucose, antioxidant, ketone |
05/26/1992 | US5116847 Use of loperamide and related compounds for treatment of respiratory disease symptoms |
05/26/1992 | US5116839 Treatment of senility |
05/26/1992 | US5116819 Enteral diet for patients with pulmonary disease |
05/26/1992 | US5116817 LHRH preparations for intranasal administration |
05/26/1992 | US5116621 Anti-inflammatory analgesic patch |
05/26/1992 | US5116619 Vaginal progesterone tablet |
05/26/1992 | US5116617 Pharmaceutical composition for topical use in the treatment of the capillary fragility |
05/26/1992 | US5116603 Oral antifungal preventative, and method of use |
05/26/1992 | US5116536 Preparation of pharmaceutical or cosmetic dispersions |
05/26/1992 | US5115805 Ultrasound-enhanced delivery of materials into and through the skin |
05/26/1992 | CA1301682C Microbial encapsulation |